Citation
Braidy, Nady, et al. "Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease." CNS & Neurological Disorders Drug Targets, vol. 16, no. 4, 2017, pp. 387-397.
Braidy N, Behzad S, Habtemariam S, et al. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. CNS Neurol Disord Drug Targets. 2017;16(4):387-397.
Braidy, N., Behzad, S., Habtemariam, S., Ahmed, T., Daglia, M., Nabavi, S. M., Sobarzo-Sanchez, E., & Nabavi, S. F. (2017). Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. CNS & Neurological Disorders Drug Targets, 16(4), 387-397. https://doi.org/10.2174/1871527316666170328113309
Braidy N, et al. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. CNS Neurol Disord Drug Targets. 2017;16(4):387-397. PubMed PMID: 28474543.
TY - JOUR
T1 - Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
AU - Braidy,Nady,
AU - Behzad,Sahar,
AU - Habtemariam,Solomon,
AU - Ahmed,Touqeer,
AU - Daglia,Maria,
AU - Nabavi,Seyed Mohammad,
AU - Sobarzo-Sanchez,Eduardo,
AU - Nabavi,Seyed Fazel,
PY - 2016/08/29/received
PY - 2017/01/31/revised
PY - 2017/03/03/accepted
PY - 2017/5/6/pubmed
PY - 2018/4/17/medline
PY - 2017/5/6/entrez
KW - Alzheimer's disease
KW - Parkinson’s disease
KW - amyloid
KW - nobiletin
KW - tangeretin
KW - tau
SP - 387
EP - 397
JF - CNS & neurological disorders drug targets
JO - CNS Neurol Disord Drug Targets
VL - 16
IS - 4
N2 - Neurodegenerative diseases, namely Alzheimer's disease and Parkinson's disease represent a deleterious impact worldwide. Despite extensive preclinical and clinical research in neurodegenerative disorders, therapeutic strategies aimed at the prevention and chronic treatment of neurodegenerative conditions have not been successfully translated to the clinic. Therefore, the identification of novel pharmacological intervention derived from natural products is warranted. Nobiletin and tangeretin are important citrus flavonoids derived from the peel and other parts of Citrus L. genus, and have been shown to exhibit neuroprotective effects in several in vitro and in vivo studies. Apart from there antioxidant and anti-inflammatory effects, nobiletin and tangeretin have been shown to attenuate cholinergic deficits, reduce the abnormal accumulation of neurotoxic amyloid-beta peptides, reverse N-methyl- D-aspartate (NMDA) receptor hypofunction, ameliorate ischemic injury, inhibit hyperphosphorylation of tau protein, enhance neprilysin levels, modulate several signaling cascades, and protect against 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. Taken together, these naturally occurring phytochemicals may represent beneficial drug candidates for the treatment and prevention of Alzheimer's and Parkinson's disease.
SN - 1996-3181
UR - https://www.unboundmedicine.com/medline/citation/28474543/Neuroprotective_Effects_of_Citrus_Fruit_Derived_Flavonoids_Nobiletin_and_Tangeretin_in_Alzheimer's_and_Parkinson's_Disease_
DB - PRIME
DP - Unbound Medicine
ER -